Insights

Gathering insights about Nyla…

Similar companies to Nyla

Nyla Tech Stack

Nyla uses 8 technology products and services including Salesforce, Google Cloud, Emotion, and more. Explore Nyla's tech stack below.

Salesforce
Customer Relationship Management
Google Cloud
Infrastructure As A Service
Emotion
Javascript Frameworks
Open Graph
Miscellaneous
PWA
Miscellaneous
Webflow
Page Builders
X-XSS-Protection
Security
Cloudflare Bot Management
Security

Media & News

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
Here is how Alnylam Pharmaceuticals (ALNY) and argenex SE (ARGX) have performed compared to their sector so far this year.
Dec 25, 2024 | www.zacks.com
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
Here, we present four biotech stocks, namely SRPT, ADMA, EXEL and ALNY, which most Wall Street analysts are optimistic about. These companies have upside potential for 2025, backed by strong fundamentals.
Dec 19, 2024 | www.zacks.com
What Makes Alnylam (ALNY) a New Buy Stock
Alnylam (ALNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dec 04, 2024 | www.zacks.com
Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Piper Sandler 36th Annual Healthcare Conference on Thursday, December 5, 2024 at 11:00 am ET at the Lotte New York Palace Hotel in New York City. A live audio webcast of the presentation will be available on the Investors section of the Company's website at www.alnylam.com/events. A replay will be available.
Nov 27, 2024 | www.businesswire.com
FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
ALNY reports submitting an sNDA in the United States, seeking the label expansion of Amvuttra to treat ATTR amyloidosis with cardiomyopathy.
Nov 26, 2024 | www.zacks.com
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental New Drug Application (sNDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Based on the Company's use of a Priority Review Voucher, the FDA has set an action date goal of Mar.
Nov 25, 2024 | www.businesswire.com
ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
Alnylam shares interim phase I amyloidosis study data on nucresiran, showing rapid TTR reduction sustained for six months after a single dose.
Nov 18, 2024 | www.zacks.com

Nyla's Email Address Formats

Nyla uses at least 1 format(s):

Nyla Email Formats	Example	Percentage
First@nyla.app	John@nyla.app	50%
First@nyla.app	John@nyla.app	50%

Frequently Asked Questions

Where is Nyla's headquarters located?

Nyla's main headquarters is located at Denver, CO 80202 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Nyla's stock symbol?

Nyla is a publicly traded company; the company's stock symbol is ALNY.

What is Nyla's official website and social media links?

Nyla's official website is nyla.app and has social profiles on LinkedIn.

How much revenue does Nyla generate?

As of September 2024, Nyla's annual revenue reached $1.8M.

What is Nyla's NAICS code?

Nyla's NAICS code is 5112 - Software Publishers.

How many employees does Nyla have currently?

As of September 2024, Nyla has approximately 26 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Technology Officer: J. F.Chief Product Officer: S. D.Chief Design Officer: W. S.. Explore Nyla's employee directory with LeadIQ.

What industry does Nyla belong to?

Nyla operates in the Software Development industry.

What technology does Nyla use?

Nyla's tech stack includes SalesforceGoogle CloudEmotionOpen GraphPWAWebflowX-XSS-ProtectionCloudflare Bot Management.

What is Nyla's email format?

Nyla's email format typically follows the pattern of . Find more Nyla email formats with LeadIQ.

How much funding has Nyla raised to date?

As of September 2024, Nyla has raised $3.3M in funding. The last funding round occurred on Sep 01, 2021 for $3.3M.

When was Nyla founded?

Nyla was founded in 2019.

Nyla

Software DevelopmentColorado, United States11-50 Employees

Nyla is a fast and modern frontend platform for the world's best ecommerce brands. We combine the benefits of blazing-fast headless ecommerce with effortless management and stunning no-code design.

Company Overview

Headquarters: Denver, CO 80202 US
Website: nyla.app
Stock Symbol: ALNY
NAICS Code: 5112 - Software Publishers
Founded: 2019
Employees: 11-50

Media & News

Funding & Financials

$3.3M
Nyla has raised a total of $3.3M of funding over 1 rounds. Their latest funding round was raised on Sep 01, 2021 in the amount of $3.3M.
$10M
Nyla's revenue is in the range of $10M

Funding & Financials

$3.3M
Nyla has raised a total of $3.3M of funding over 1 rounds. Their latest funding round was raised on Sep 01, 2021 in the amount of $3.3M.
$10M
Nyla's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Nyla

Cognigy

Amplify.ai

Linc

Conversica

Botpress

Nyla Tech Stack

Media & News

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

What Makes Alnylam (ALNY) a New Buy Stock

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study

Nyla's Email Address Formats

Frequently Asked Questions

Where is Nyla's headquarters located?

What is Nyla's stock symbol?

What is Nyla's official website and social media links?

How much revenue does Nyla generate?

What is Nyla's NAICS code?

How many employees does Nyla have currently?

What industry does Nyla belong to?

What technology does Nyla use?

What is Nyla's email format?

How much funding has Nyla raised to date?

When was Nyla founded?

Nyla

Company Overview

Media & News

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

What Makes Alnylam (ALNY) a New Buy Stock

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?